![](/images/graphics-bg.png)
The effect of tamoxifen and luteinizing hormone-releasing hormone (LHRH) analogue on estrogen level in women with breast cancer
المؤلفون المشاركون
Hammad, Sad
Jabbar, Inas Abd al-Karim
المصدر
العدد
المجلد 10، العدد 2 (30 يونيو/حزيران 2015)، ص ص. 41-55، 15ص.
الناشر
جامعة ذي قار قسم البحث و التطوير
تاريخ النشر
2015-06-30
دولة النشر
العراق
عدد الصفحات
15
التخصصات الرئيسية
الملخص EN
Estrogen exposure is a major risk factor for breast cancer.
Increased estrogen responsiveness of breast epithelium may enhance this effect.
Surgical or medical castration and antiestrogenic treatment with tamoxifen are common endocrine treatments for premenopausal women with breast cancer.
However, tamoxifen therapy induces high levels of plasma estradiol, with unknown long-term effects.
In this study, we investigated the effect of combining the luteinizing hormone-releasing hormone agonist with tamoxifen and measuring estradiol level .
method : Are taking random samples of breast cancer patients under treatment of patients attending the Institute of Atomic Radiation in Baghdad , and specifically who use Tamoxifen ( 20 mg/day) .
100 samples and 30 sample as a control there age ( 20 – 80).
Approximately 3ml of blood are collected from each women using standard procedures.
And then measuring the level of estradiol E2 hormone ,Measurement of the liver enzymes ( GOT,GPT,ALP,LDH and GGT ) and billirubin for study the liver health results : combined treatment with tamoxifen and LHRH analogue cause reduced in estradiol level (37.3634±45.02893) P ≤ o.o1 which is consider the main cause of breast cancer in this study group while the control group was in normal range (93.3700±51.07188) and the level of liver enzymes and total billirubin was in normal range and there was no significant change.
Conclusion : combining the luteinizing hormone-releasing hormone agonist with tamoxifen leads to reduced the level of estradiol E2 hormone while treatment tamoxifen alone cause elevating these hormone , also these drugs didn’t effected on the liver health.
نمط استشهاد جمعية علماء النفس الأمريكية (APA)
Jabbar, Inas Abd al-Karim& Hammad, Sad. 2015. The effect of tamoxifen and luteinizing hormone-releasing hormone (LHRH) analogue on estrogen level in women with breast cancer. University of Thi-Qar Journal،Vol. 10, no. 2, pp.41-55.
https://search.emarefa.net/detail/BIM-654862
نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)
Jabbar, Inas Abd al-Karim& Hammad, Sad. The effect of tamoxifen and luteinizing hormone-releasing hormone (LHRH) analogue on estrogen level in women with breast cancer. University of Thi-Qar Journal Vol. 10, no. 2 (Jun. 2015), pp.41-55.
https://search.emarefa.net/detail/BIM-654862
نمط استشهاد الجمعية الطبية الأمريكية (AMA)
Jabbar, Inas Abd al-Karim& Hammad, Sad. The effect of tamoxifen and luteinizing hormone-releasing hormone (LHRH) analogue on estrogen level in women with breast cancer. University of Thi-Qar Journal. 2015. Vol. 10, no. 2, pp.41-55.
https://search.emarefa.net/detail/BIM-654862
نوع البيانات
مقالات
لغة النص
الإنجليزية
الملاحظات
Includes bibliographical references : p. 50-55
رقم السجل
BIM-654862
قاعدة معامل التأثير والاستشهادات المرجعية العربي "ارسيف Arcif"
أضخم قاعدة بيانات عربية للاستشهادات المرجعية للمجلات العلمية المحكمة الصادرة في العالم العربي
![](/images/ebook-kashef.png)
تقوم هذه الخدمة بالتحقق من التشابه أو الانتحال في الأبحاث والمقالات العلمية والأطروحات الجامعية والكتب والأبحاث باللغة العربية، وتحديد درجة التشابه أو أصالة الأعمال البحثية وحماية ملكيتها الفكرية. تعرف اكثر
![](/images/kashef-image.png)